Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 GP27.01 | DOI: 10.1530/endoabs.37.GP.27.01

ECE2015 Guided Posters Thyroid – hyperthyroidism and treatment (8 abstracts)

The effect of TSH suppression therapy on the cortical bone geometry in the patients with differentiated thyroid cancer

Jae Hoon Moon 1 , Hoon Sung Choi 3 , Chan Hyun Jung 2 , Kyung Young Kim 2 , Young Joo Park 2 , Do Joon Park 2 & Kyong Yeun Kim 1


1Seoul National University Bounding Hospital, Seongnam, Republic of Korea; 2Seoul National University Hospital, Seoul, Republic of Korea; 3Kangwon National University Hospital, Kangwon-do, Republic of Korea.


Background: TSH suppression therapy has been associated with hip and vertebral fracture. However, the relationship between TSH suppression and bone mineral density (BMD) remains controversial. The aim of this study was to evaluate the effect of TSH suppression therapy on cortical bone geometry in differentiated thyroid cancer (DTC) patients.

Methods: This study included 122 subjects (19 men, 27 premenopausal women, and 75 postmenopausal women) who have been on TSH-suppressive doses of levothyroxine after thyroidectomy due to DTC during at least 3 years. Patients were matched with 366 healthy controls. Dual-energy X-ray absorptiometry at the hip and lumbar spine was performed and geometry of hip was analysed.

Results: The mean TSH level was 0.23±0.44 μIU/ml and the proportion of calcium/vitamin D supplement was 51.6% in 122 subjects. TSH suppression therapy did not impair the BMD of patients compared with controls. In addition, cortical bone geometry including cortical width of femur neck (5.5±1.9 vs 5.4±1.1, P=0.903 in men, 5.9±1.1 vs 5.0±0.6, P=0.079 in premenopausal women, and 5.0±0.9 vs 5.1±0.7, P=0.563 in postmenopausal women) and buckling ratio (4.0±2.1 vs 4.0±1.4 in male, 3.0±0.8 vs 3.4±0.3 in premenopausal women, and 3.6±0.7 vs 3.5±0.6 in postmenopausal women) showed no significant difference in patients compared to healthy controls.

Conclusions: There was little evidence of adverse effect of TSH suppression on cortical bone geometry in DTC patients.

Article tools

My recent searches

No recent searches.